Wednesday, February 10, 2010, 7:33pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

AVI Biopharma, Inc. (AVII)

At 5:00AM SGT: 1.45 USD   0.00 (0.00%)  
 MORE ON AVII 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 AVI BioPharma, Inc. (NGM:AVII) Delayed quote dataEdit
Last Trade:1.45 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:1.45
Open:N/A
Bid:1.30 x 2500
Ask:1.75 x 500
1y Target Est:3.75
Day's Range:N/A - N/A
52wk Range:0.52 - 2.73
Volume:0
Avg Vol (3m):1,312,840
Market Cap:160.13M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add AVII to Portfolio   Download Data

 HEADLINES 
•UPDATE - AVI genetic disorder drug gets orphan status in EU
at Reuters (Fri, Feb 5)
•AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy
Marketwire (Fri, Feb 5)
•AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicology
Marketwire (Thu, Feb 4)
•AVI BIOPHARMA INC Files SEC form 8-K, Other Events
EDGAR Online (Tue, Jan 19)
•3 Stocks Hitting High Notes
at Motley Fool (Tue, Jan 12)
•AVI BIOPHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 24)
•Systemic Treatment With AVI-4658 Demonstrates RNA Exon Skipping and Dystrophin Protein Expression in Duchenne Muscular Dystrophy Patients
Marketwire (Tue, Dec 22)
•AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
Marketwire (Thu, Nov 19)
•AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day
Marketwire (Wed, Nov 18)
•AVI BIOPHARMA INC Financials
EDGAR Online Financials (Fri, Nov 13)
More Headlines for AVII...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.36
EPS Est (in 2 years) (Dec-10) :-0.23
Avg Rec (current)*:1.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
AVI BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products based on antisense and cancer immunotherapy technology.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices